Michael Andrew Postow


Ontology type: schema:Person     


Person Info

NAME

Michael Andrew

SURNAME

Postow

Publications in SciGraph latest 50 shown

  • 2022-04-21 The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021 in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2021-11-01 Improved prediction of immune checkpoint blockade efficacy across multiple cancer types in NATURE BIOTECHNOLOGY
  • 2021-07-08 Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade in NATURE MEDICINE
  • 2021-06-30 Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd–5th, 2020, Italy) in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2021-02-01 Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors in NATURE COMMUNICATIONS
  • 2021-01-04 The association between tumor mutational burden and prognosis is dependent on treatment context in NATURE GENETICS
  • 2020-09-07 Perspectives in melanoma: meeting report from the “Melanoma Bridge” (December 5th–7th, 2019, Naples, Italy) in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2020-04-16 The Great Debate at “Melanoma Bridge”, Naples, December 7th, 2019 in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2019-12-17 Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade in ANNALS OF SURGICAL ONCOLOGY
  • 2019-04-29 Rational design of anti-GITR-based combination immunotherapy in NATURE MEDICINE
  • 2018-10-19 Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2018-07-21 Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November–2 December, 2017, Naples, Italy) in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2018-01-10 High response rate to PD-1 blockade in desmoplastic melanomas in NATURE
  • 2017-11-16 Future perspectives in melanoma research “Melanoma Bridge”, Napoli, November 30th–3rd December 2016 in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2017-11-03 The need for a network to establish and validate predictive biomarkers in cancer immunotherapy in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2017-10-17 Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-04-18 Response after treatment with pembrolizumab in a patient with myelophthisis due to melanoma: the role of checkpoint inhibition in the bone in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-04-10 T-cell invigoration to tumour burden ratio associated with anti-PD-1 response in NATURE
  • 2017-03-16 Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma in ANNALS OF SURGICAL ONCOLOGY
  • 2017-03-01 Patient perspectives on ipilimumab across the melanoma treatment trajectory in SUPPORTIVE CARE IN CANCER
  • 2017-02-21 Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-01-16 Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2016-11-16 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-11-16 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-08-23 Head and Neck Cutaneous Melanoma in HEAD AND NECK CANCER
  • 2016-08-23 Primary Mucosal Melanomas of the Head and Neck in HEAD AND NECK CANCER
  • 2016-07-25 Melanoma and immunotherapy bridge 2015 in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2016-02-27 Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition in CURRENT ONCOLOGY REPORTS
  • 2015-11-25 Checkpoint Blockade for the Treatment of Advanced Melanoma in MELANOMA
  • 2015-10-07 Alternative transcription initiation leads to expression of a novel ALK isoform in cancer in NATURE
  • 2015-06-16 Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-01-13 Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25 in CELL RESEARCH
  • 2014-11-06 T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-11-06 Patterns of long-term survival following Ipilimumab (Ipi): the Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-10-14 Ipilimumab in patients with melanoma and autoimmune disease in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-06-18 Opportunistic infections in patients treated with immunotherapy for cancer in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-05-06 Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2013-10-31 Markers for Anti-cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Therapy in Melanoma in MOLECULAR DIAGNOSTICS FOR MELANOMA
  • 2013-08-10 Checkpoint Modulation in Melanoma: An Update on Ipilimumab and Future Directions in CURRENT ONCOLOGY REPORTS
  • 2012-10-04 Inherited gastrointestinal stromal tumor syndromes: mutations, clinical features, and therapeutic implications in CLINICAL SARCOMA RESEARCH
  • 2012-06-04 Mucosal Melanoma: Pathogenesis, Clinical Behavior, and Management in CURRENT ONCOLOGY REPORTS
  • 2011-06-10 A Man with Klinefelter’s Syndrome and New Abdominal Distension: A Discussion of Evaluation and Management in JOURNAL OF GASTROINTESTINAL CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.51462.34", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5386.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.468198.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.490281.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413471.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.240324.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410718.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.266623.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417307.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419546.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413734.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418165.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.424926.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.280062.e", 
            "type": "Organization"
          }
        ], 
        "familyName": "Postow", 
        "givenName": "Michael Andrew", 
        "id": "sg:person.0663446543.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663446543.06"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-09-02T16:35", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/person/person_999.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0663446543.06'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0663446543.06'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0663446543.06'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0663446543.06'


     

    This table displays all metadata directly associated to this object as RDF triples.

    42 TRIPLES      10 PREDICATES      24 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0663446543.06 schema:affiliation N09269a70d05e4186a461e5013d6d844e
    2 grid-institutes:grid.240324.3
    3 grid-institutes:grid.266623.5
    4 grid-institutes:grid.280062.e
    5 grid-institutes:grid.410718.b
    6 grid-institutes:grid.413471.4
    7 grid-institutes:grid.413734.6
    8 grid-institutes:grid.417307.6
    9 grid-institutes:grid.418165.f
    10 grid-institutes:grid.419546.b
    11 grid-institutes:grid.424926.f
    12 grid-institutes:grid.468198.a
    13 grid-institutes:grid.490281.6
    14 grid-institutes:grid.5386.8
    15 schema:familyName Postow
    16 schema:givenName Michael Andrew
    17 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663446543.06
    18 schema:sdDatePublished 2022-09-02T16:35
    19 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    20 schema:sdPublisher N1937dfc15bcf42f09fa41128b482e956
    21 sgo:license sg:explorer/license/
    22 sgo:sdDataset persons
    23 rdf:type schema:Person
    24 N09269a70d05e4186a461e5013d6d844e schema:affiliation grid-institutes:grid.51462.34
    25 sgo:isCurrent true
    26 rdf:type schema:OrganizationRole
    27 N1937dfc15bcf42f09fa41128b482e956 schema:name Springer Nature - SN SciGraph project
    28 rdf:type schema:Organization
    29 grid-institutes:grid.240324.3 schema:Organization
    30 grid-institutes:grid.266623.5 schema:Organization
    31 grid-institutes:grid.280062.e schema:Organization
    32 grid-institutes:grid.410718.b schema:Organization
    33 grid-institutes:grid.413471.4 schema:Organization
    34 grid-institutes:grid.413734.6 schema:Organization
    35 grid-institutes:grid.417307.6 schema:Organization
    36 grid-institutes:grid.418165.f schema:Organization
    37 grid-institutes:grid.419546.b schema:Organization
    38 grid-institutes:grid.424926.f schema:Organization
    39 grid-institutes:grid.468198.a schema:Organization
    40 grid-institutes:grid.490281.6 schema:Organization
    41 grid-institutes:grid.51462.34 schema:Organization
    42 grid-institutes:grid.5386.8 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...